I Mab Biopharma Is A Global Biotech Company Based In Rockvillemarylandwith Additional Operations In Hong Kong And Chinathe Company Focuses On Developing Innovative Immunotherapiesprimarily For Cancer Treatmentand Is Listed On The Nasdaq Under The Ticker Symbol Imab I Mab Specializes In Precision Immuno Oncology Agents And Transformational Medicinesits Product Pipeline Includes Several Notable Candidatessuch As Tj202A Cd38 Antibody For Multiple Myelomatj101A Recombinant Human Growth Hormone For Pediatric Growth Hormone Deficiencyand Tj301An Il 6 Inhibitor For Ulcerative Colitisthe Company Employs Advanced Molecular Engineering Platforms To Create Drug Molecules With Specific Biological Propertiesaiming To Address Significant Medical Needs In Oncology And Autoimmune Diseases
